These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16178757)

  • 1. NMDA antagonists and neuropathic pain--multiple drug targets and multiple uses.
    Chizh BA; Headley PM
    Curr Pharm Des; 2005; 11(23):2977-94. PubMed ID: 16178757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate-based therapeutic approaches: NR2B receptor antagonists.
    Gogas KR
    Curr Opin Pharmacol; 2006 Feb; 6(1):68-74. PubMed ID: 16376149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-methyl-D-aspartate receptor (NMDA) antagonists as potential pain therapeutics.
    Brown DG; Krupp JJ
    Curr Top Med Chem; 2006; 6(8):749-70. PubMed ID: 16719815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemical biology of clinically tolerated NMDA receptor antagonists.
    Chen HS; Lipton SA
    J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic N-methyl-D-aspartate receptor antagonists: will reality meet expectation?
    Smith PF
    Curr Opin Investig Drugs; 2003 Jul; 4(7):826-32. PubMed ID: 14619404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials.
    Sang CN
    J Pain Symptom Manage; 2000 Jan; 19(1 Suppl):S21-5. PubMed ID: 10687335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined opioid-NMDA antagonist therapies. What advantages do they offer for the control of pain syndromes?
    Wiesenfeld-Hallin Z
    Drugs; 1998 Jan; 55(1):1-4. PubMed ID: 9463786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecules targeting the NMDA receptor complex as drugs for neuropathic pain.
    Planells-Cases R; Pérez-Payá E; Messeguer A; Carreño C; Ferrer-Montiel A
    Mini Rev Med Chem; 2003 Nov; 3(7):749-56. PubMed ID: 14529515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of NMDA-receptor antagonists in the treatment of chronic pain.
    Hewitt DJ
    Clin J Pain; 2000 Jun; 16(2 Suppl):S73-9. PubMed ID: 10870744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiallodynic effect of NMDA antagonists in neuropathic pain outlasts the duration of the in vivo NMDA antagonism.
    Christoph T; Schiene K; Englberger W; Parsons CG; Chizh BA
    Neuropharmacology; 2006 Jul; 51(1):12-7. PubMed ID: 16616769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonists selective for NMDA receptors containing the NR2B subunit.
    Chenard BL; Menniti FS
    Curr Pharm Des; 1999 May; 5(5):381-404. PubMed ID: 10213801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NMDA receptor complex: a long and winding road to therapeutics.
    Wood PL
    IDrugs; 2005 Mar; 8(3):229-35. PubMed ID: 15772895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn.
    Boyce S; Wyatt A; Webb JK; O'Donnell R; Mason G; Rigby M; Sirinathsinghji D; Hill RG; Rupniak NM
    Neuropharmacology; 1999 May; 38(5):611-23. PubMed ID: 10340299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fyn kinase-mediated phosphorylation of NMDA receptor NR2B subunit at Tyr1472 is essential for maintenance of neuropathic pain.
    Abe T; Matsumura S; Katano T; Mabuchi T; Takagi K; Xu L; Yamamoto A; Hattori K; Yagi T; Watanabe M; Nakazawa T; Yamamoto T; Mishina M; Nakai Y; Ito S
    Eur J Neurosci; 2005 Sep; 22(6):1445-54. PubMed ID: 16190898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMDA receptors as targets for drug action in neuropathic pain.
    Parsons CG
    Eur J Pharmacol; 2001 Oct; 429(1-3):71-8. PubMed ID: 11698028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways.
    Chizh BA
    J Psychopharmacol; 2007 May; 21(3):259-71. PubMed ID: 17591654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone for neuropathic pain: a new use for an old drug?
    Watson CP
    Can J Neurol Sci; 2005 Aug; 32(3):271-2. PubMed ID: 16225164
    [No Abstract]   [Full Text] [Related]  

  • 18. NMDA receptor antagonists and glycine site NMDA antagonists.
    Madden K
    Curr Med Res Opin; 2002; 18 Suppl 2():s27-31. PubMed ID: 12365826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain.
    Medvedev IO; Malyshkin AA; Belozertseva IV; Sukhotina IA; Sevostianova NY; Aliev K; Zvartau EE; Parsons CG; Danysz W; Bespalov AY
    Neuropharmacology; 2004 Aug; 47(2):175-83. PubMed ID: 15223296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults.
    Lipton SA
    NeuroRx; 2004 Jan; 1(1):101-10. PubMed ID: 15717010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.